CID 141761076

Pumecitinib

Structural Information

Molecular Formula
C17H20N8O2S
SMILES
CC(C)S(=O)(=O)N1CC(C1)(CC#N)N2C=C(C(=N2)N)C3=C4C=CNC4=NC=N3
InChI
InChI=1S/C17H20N8O2S/c1-11(2)28(26,27)24-8-17(9-24,4-5-18)25-7-13(15(19)23-25)14-12-3-6-20-16(12)22-10-21-14/h3,6-7,10-11H,4,8-9H2,1-2H3,(H2,19,23)(H,20,21,22)
InChIKey
OUXYFMCMGWQWQF-UHFFFAOYSA-N
Compound name
2-[3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-1-propan-2-ylsulfonylazetidin-3-yl]acetonitrile
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

11
Patents

400.143 Da
Monoisotopic Mass

-0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 401.15028 193.9
[M+Na]+ 423.13222 201.8
[M-H]- 399.13572 193.9
[M+NH4]+ 418.17682 195.2
[M+K]+ 439.10616 200.3
[M+H-H2O]+ 383.14026 172.8
[M+HCOO]- 445.14120 198.9
[M+CH3COO]- 459.15685 198.9
[M+Na-2H]- 421.11767 191.9
[M]+ 400.14245 198.0
[M]- 400.14355 198.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe